Literature DB >> 22371920

Mounting evidence for lack of PCI benefit in stable ischemic heart disease : what more will it take to turn the tide of treatment?: comment on "initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease".

William E Boden1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22371920     DOI： 10.1001/archinternmed.2011.2321

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  6 in total

Review 1.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 2.  The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment.

Authors:  Armin Arbab-Zadeh; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2015-01-16       Impact factor: 24.094

3.  Impact of myocardial ischemia on myocardial revascularization in stable ischemic heart disease. Lessons from the COURAGE and FAME 2 trials.

Authors:  M T Torosoff; M S Sidhu; W E Boden
Journal:  Herz       Date:  2013-06       Impact factor: 1.443

4.  Extent and cost of inappropriate use of tumour markers in patients with pulmonary disease: a multicentre retrospective study in Shanghai, China.

Authors:  Haichen Zhang; Yunxiao Song; Xiong Zhang; Jun Hu; Suwei Yuan; Jin Ma
Journal:  BMJ Open       Date:  2018-02-28       Impact factor: 2.692

5.  Myocardial Revascularization in New York State: Variations in the PCI-to-CABG Ratio and Their Implications.

Authors:  Wilson Ko; Robert Tranbaugh; Jonathan D Marmur; Phyllis G Supino; Jeffrey S Borer
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

6.  Invasive and non-invasive fractional flow reserve index in validation of hemodynamic severity of intracoronary lesions.

Authors:  Jarosław Wasilewski; Kryspin Mirota; Michał Hawranek; Lech Poloński
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-06-17       Impact factor: 1.426
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.